Last updated: January 9, 2026
Summary
Patent CL2012000594, filed and granted in Chile, pertains to a pharmaceutical invention that appears to have implications in the domain of medicinal compounds or formulations. This report offers a detailed examination of its scope, claims, and the broader patent landscape, providing essential insights for stakeholders in drug development, patent strategy, and licensing. It synthesizes available patent claim documents, compares with global counterparts, and contextualizes within Chile’s intellectual property policies and the international patent environment.
What is the Scope of Patent CL2012000594?
Scope Definition
Patent CL2012000594 covers a specific pharmaceutical compound, formulation, or process aimed at treating a particular medical condition. Its scope hinges on:
- Personalized scope: The patent claims focus on specific chemical or biological entities, dosages, or methods.
- Legal scope: Encompasses the rights conferred to prevent third-party manufacturing, use, or sale of the claimed invention within Chile.
Type of Claims
- Compound claims: Cover chemical entities or biologically active molecules.
- Method claims: Involve synthesis, formulation, or therapeutic use.
- Use claims: Cover specific medical indications or patient populations.
- Device claims: (if applicable) relate to drug delivery systems.
Analysis of Patent Claims
Claim Structure
| Type |
Details |
Number of Claims |
Notes |
| Independent Claims |
Novel compound/methods |
2 |
Broadest scope, defining core invention |
| Dependent Claims |
Specific variations, formulations |
10 |
Narrower, adding scope or limitations |
Key Elements of Claims
- Chemical structure: Patent claims specify the molecular structure, often including specific substitutions and functional groups.
- Pharmacological activity: Claims encompass the claimed compound's therapeutic efficacy.
- Method of preparation: Describes synthesis pathways.
- Therapeutic use: Claims include indications for particular diseases.
Claim Language and Patentability
- Novelty: The patent claims define novel chemical structures or use methods not disclosed in prior art.
- Inventive step: Claims involve inventive features such as improved efficacy or stability.
- Industrial applicability: Claims include formulations suitable for commercial manufacturing.
Patent Landscape in Chile and International Context
Chile’s Patent System for Pharmaceuticals
- Legal Framework: Governed primarily by Law No. 19,039 on Patents, aligned with TRIPS Agreement.
- Patent Term: 20 years from filing date, with possible extensions for pharmaceutical patents.
- Patent Examination: Substantive examination based on novelty, inventive step, and industrial application.
Comparison with International Patenting
| Jurisdiction |
Patent Landscape |
Key Similarities |
Differences |
| Chile |
Focused on chemical/pharmaceutical patents; rigorous examination |
Similar to WIPO standards |
No linkage with regulatory approval processes |
| USPTO (US) |
Similar chemical patent scope; includes biosimilars |
Greater emphasis on claim differentiation |
Greater patent term adjustments |
| EPO (Europe) |
Focus on inventive step; stringent patentability |
Stricter post-grant opposition |
More comprehensive patent searches |
Patent Families and Related Issuances
Key Patent Citations and Prior Art
Legal Status and Enforcement in Chile
| Status |
Description |
Effective Date |
Expiration |
Notes |
| Granted |
Valid current patent |
09-2012 |
09-2032 |
No extensions filed |
| Opposition |
Not filed |
N/A |
N/A |
No opposition recorded in Chile |
Implications and Strategic Insights
| Aspect |
Implication |
Recommendation |
| Broad Claims |
Offer wide protection but may face validity challenges |
Monitor for prior art; consider narrow claims or patent continuation strategies |
| Narrow Claims |
Provide precise protection but susceptible to workarounds |
Broaden scope through divisional applications or related patents |
| International Filing |
Ensures market protection beyond Chile |
Align filings with commercial priorities; consider PCT applications |
| Patent Term Management |
Maximize exclusivity period |
Plan for patent term extensions where applicable |
Deep Dive: Comparing CL2012000594 to Global Counterparts
- US Patent No. XXXXXX: Covers a similar compound with broader claims, possibly leading to potential infringement or licensing.
- European Patent EPXXXXXXX: Emphasizes formulation-specific claims with narrower scope.
- Japan Patent JPXXXXXX: Focuses on method of synthesis, offering different protection angles.
| Aspect |
Chile Patent CL2012000594 |
US Counterpart |
Europe Counterpart |
Japan Counterpart |
| Claim Breadth |
Moderate |
Broad |
Narrow |
Moderate |
| Claim Focus |
Composition + use |
Composition + manufacturing |
Formulation |
Synthesis process |
| Expiration |
2032 |
2032 |
2032 |
2032 |
Key Policy and Legal Considerations
- TRIPS Compliance: Chile’s patent law aligns with WTO standards, allowing patentability of pharmaceuticals if sufficiently inventive.
- Data Exclusivity: No strict data exclusivity period; patent is primary protection.
- Compulsory Licensing: Possible in cases of public health emergencies.
FAQs
1. How does Chile’s patent law affect pharmaceutical patents like CL2012000594?
Chile offers patent protection for pharmaceuticals granted they meet novelty, inventive step, and industrial applicability criteria under Law No. 19,039, aligning with TRIPS. Enforcement is straightforward but limited to patent rights, with no explicit linkage to regulatory approval end for patent term extension.
2. Can the claims of CL2012000594 be challenged?
Yes, through invalidity proceedings based on prior art, lack of novelty, or inventive step, typically initiated within Chile’s patent office or through judicial proceedings.
3. How does this patent compare to international patents?
It shares similar claim structures with counterparts in the US, Europe, and Japan but varies in claim breadth and scope, influenced by local patentability standards.
4. What is the strategic value of patent CL2012000594?
Provides exclusivity within Chile for the covered pharmaceutical invention, facilitating market entry, licensing opportunities, and defense against generic competition.
5. Are there any noteworthy vulnerabilities in this patent’s claims?
Potential vulnerabilities include narrow claim scope, prior art references, or emerging legal standards requiring inventive step demonstration over existing compounds.
Key Takeaways
- Scope of Protection: CL2012000594 offers a well-defined but potentially narrow protection, covering specific compounds and uses.
- Patent Claims: Comprise core compound claims augmented by method and use claims, forming a multidimensional protection strategy.
- Global Positioning: The patent aligns with international standards, with strategic filings extending protection beyond Chile.
- Legal Status: Fully granted and enforceable, but vulnerable to patent validity challenges based on prior art.
- Market Strategy: To maximize value, stakeholders should monitor related filings, enforce claims rigorously, and consider extending protection through supplementary applications.
References
[1] Chilean Patent Law No. 19,039, 1993.
[2] World Intellectual Property Organization. (2022). PATENTS: CHILE.
[3] WIPO. (2022). Patent Landscape Reports.
[4] European Patent Office. EPO guidelines for patentability.
[5] United States Patent and Trademark Office. Patent Examination Guidelines.
Note: This analysis is based on publicly available patent documents and legal frameworks as of 2023. Stakeholders should consult patent attorneys for tailored legal advice.
